Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Trial of 5-Fluorouracil, Leucovorin, and Oxaliplatin (mFOLFOX6) Chemotherapy Plus Bevacizumab for Patients With Unresectable Stage IV Colon Cancer and a Synchronous Asymptomatic Primary Tumor

NCT00321828 is registered in ClinicalTrials.gov with NSABP Foundation Inc as lead sponsor.

NCT NCT00321828
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00321828 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Trial of 5-Fluorouracil, Leucovorin, and Oxaliplatin (mFOLFOX6) Chemotherapy Plus Bevacizumab for Patients With Unresectable Stage IV Colon Cancer and a Synchronous Asymptomatic Primary Tumor
Lead sponsor
NSABP Foundation Inc
Phase
Phase 2
Overall status
Completed
Start date
March 31, 2006
Completion date
December 31, 2012
Enrollment
90 (actual)
Sites
163

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal cancer